1. Home
  2. BPTH vs TAOP Comparison

BPTH vs TAOP Comparison

Compare BPTH & TAOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPTH
  • TAOP
  • Stock Information
  • Founded
  • BPTH 2007
  • TAOP 1993
  • Country
  • BPTH United States
  • TAOP China
  • Employees
  • BPTH N/A
  • TAOP N/A
  • Industry
  • BPTH Biotechnology: Pharmaceutical Preparations
  • TAOP Computer Software: Prepackaged Software
  • Sector
  • BPTH Health Care
  • TAOP Technology
  • Exchange
  • BPTH Nasdaq
  • TAOP Nasdaq
  • Market Cap
  • BPTH 2.2M
  • TAOP 2.5M
  • IPO Year
  • BPTH N/A
  • TAOP N/A
  • Fundamental
  • Price
  • BPTH $0.87
  • TAOP $0.84
  • Analyst Decision
  • BPTH Strong Buy
  • TAOP
  • Analyst Count
  • BPTH 2
  • TAOP 0
  • Target Price
  • BPTH $30.00
  • TAOP N/A
  • AVG Volume (30 Days)
  • BPTH 81.3K
  • TAOP 190.6K
  • Earning Date
  • BPTH 11-13-2024
  • TAOP 09-05-2024
  • Dividend Yield
  • BPTH N/A
  • TAOP N/A
  • EPS Growth
  • BPTH N/A
  • TAOP N/A
  • EPS
  • BPTH N/A
  • TAOP 0.50
  • Revenue
  • BPTH N/A
  • TAOP $42,636,173.00
  • Revenue This Year
  • BPTH N/A
  • TAOP N/A
  • Revenue Next Year
  • BPTH N/A
  • TAOP N/A
  • P/E Ratio
  • BPTH N/A
  • TAOP $1.32
  • Revenue Growth
  • BPTH N/A
  • TAOP 37.49
  • 52 Week Low
  • BPTH $0.86
  • TAOP $0.39
  • 52 Week High
  • BPTH $21.60
  • TAOP $2.65
  • Technical
  • Relative Strength Index (RSI)
  • BPTH 34.38
  • TAOP 68.08
  • Support Level
  • BPTH $0.86
  • TAOP $0.54
  • Resistance Level
  • BPTH $0.92
  • TAOP $0.98
  • Average True Range (ATR)
  • BPTH 0.06
  • TAOP 0.11
  • MACD
  • BPTH 0.01
  • TAOP 0.02
  • Stochastic Oscillator
  • BPTH 5.79
  • TAOP 68.18

About BPTH Bio-Path Holdings Inc.

Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.

About TAOP Taoping Inc.

Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.

Share on Social Networks: